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In this issue of Immunity, Gordon et al. (2012) analyzed the role of the transcription factors T-bet and Eome-
sodermin in natural killer (NK) cell development, revealing a distinct spatiotemporal requirement of these
factors for NK cell maturation.NK cells are innate lymphocytes that
can be cytotoxic and secrete cytokines
such as interferon-g (IFN-g) (Vivier et al.,
2011). NK cells contribute to the control
of microbial infections, tumor develop-
ment, and placentation. NK cells also
participate to the shaping of the adaptive
immune response (Vivier et al., 2011). NK
cell development takes place in the liver
during fetal life and in the bone marrow
(BM) after birth. The transition from
common lymphoid progenitors (CLPs) to
NK cells remains to be fully defined.
In this issue of Immunity, Gordon et al.
(2012) addressed the spatiotemporal
involvement of two T-box transcription
factors, T-box expressed in T cells
(T-bet) and Eomesodermin (Eomes), in
mouse NK cell development. They pro-
posed a revised model of NK cell differ-
entiation based on the transient cell
surface expression of the tumor necrosis
factor-related apoptosis-inducing ligand
(TRAIL) and the sequential usage of T-
bet and Eomes. Starting from pre-pro
NK cells (CD127+Id22+), which repre-
sents the earliest committed NK-cell
progenitor, a model of NK cell differenti-
ation based on the sequential and stable
acquisition of CD122 (stage 1), NK1.1
(stage 2), NKp46 (stage 3), CD16,
NKG2D, DX5 (stage 4), CD11b (stage
5), and KLRG1, CD43 (stage 6) has
been recently proposed (Figure 1;
Narni-Mancinelli et al., 2011). The report
from Gordon et al. (2012) showing that
TRAIL is a maturation marker can thus
define an intermediate stage of NK
cell development, NK1.1+NKp46+TRAIL+
DX5T-bet+Eomes (stage 3a) (Figure 1).
So far, T-bet and Eomes have been
mostly studied in T helper 1 (Th1) cell dif-
ferentiation of CD4+ T cells, in the acqui-sition of T cell cytolytic activities, and in
the generation of memory lymphocytes.
A pioneering work from the Glimcher
laboratory has shown that an NK cell-
autonomous T-bet deficiency leads to
reduced numbers of stage 4 NK1.1+
DX5+ NK cells and no expression of
CD43 on NK cells, reflecting the absence
of terminally differentiated NK cell popula-
tion (stage 6) (Townsend et al., 2004). This
study also showed that T-bet-deficient
NK cells display an increased turnover
and an enhanced sensitivity to cell
apoptosis that could account for the
defect in NK cell number in these mice.
Later, T-bet has been recognized to drive
the expression of the spingosine-1-phos-
phate receptor 5 (S1P5) that governs the
egress of NK cells from BM and lymph
nodes (LN) into the blood (Walzer et al.,
2007; Jenne et al., 2009). Eomes, which
shares similar functions as T-bet in
T cells, is highly expressed in fully differ-
entiated NK cells, but the requirement
for Eomes in NK cell development and
differentiation was unknown.
Gordon et al. (2012) focused their work
on NK1.1+NKp46+TRAIL+DX5 immature
NK cells. TRAIL is known as the dominant
cytotoxic effector molecule expressed by
NK cells in fetal mice (Takeda et al., 2005).
TRAIL+ NK cells have also been described
as immature NK cells in the liver of adult
mice. Adoptive transfer of either adult liver
or neonatal TRAIL+ NK cells resulted in the
appearance of TRAIL NK cells with a
mature phenotype, demonstrating that
TRAIL+ NK cells represent an interme-
diate immature subset that can give rise
to mature NK cells. Gordon et al. (2012)
confirmed that TRAIL+ NK cells constitute
an intermediate stage of NK cell differen-
tiation but also showed the presence ofImmunityminute amounts of this population in all
organs of adult mice. TRAIL+ immature
NK cells were present in T-bet-deficient
neonate livers but not in T-bet-deficient
adult mice. These results suggested
that T-bet expression is required for
the stabilization of TRAIL+ immature NK
cells and that the liver provides an
enabling environment for the mainte-
nance of this population as opposed
to the BM. TRAIL+ NK cells were lost
upon T-bet deletion in NK cells purified
from BM or liver further developing into
Rag1/Il2rg/ mice.
Eomes-deficient mice exhibited re-
duced numbers of NK cells. Gordon
et al. (2012) showed that expression of
DX5 and Eomes correlated with the ex-
pression of S1P1 and S1P5. These two
S1P receptors are required for an efficient
egress of NK cells from the BM and LN
(Jenne et al., 2009; Walzer et al., 2007),
providing a likely explanation for the
reduction in peripheral NK cell counts in
Eomes-deficient mice as compared to
WT mice. Eomes-deficient NK cells also
displayed a cell-autonomous defect in
the transition from TRAIL+DX5 to TRAIL
DX5+ NK cells. In addition, Gordon et al.
(2012) elegantly showed that the temporal
deletion of Eomes in DX5+ NK cells from
BM or liver give rise to the accumulation
of TRAIL+DX5 NK cells, indicating that
Eomes is required for the maturation of
TRAIL+ NK cells into mature DX5+ NK
cells. It still remains to be confirmed
whether all mature DX5+ NK cells transit
through an immature TRAIL+ stage,
because this stage appears to be by-
passed in T-bet-deficient mice. Cell fate
mapping experiment tracing TRAIL ex-
pression will be necessary to resolve this
issue. Consistent with the incomplete36, January 27, 2012 ª2012 Elsevier Inc. 1
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Figure 1. TRAIL, T-bet, and Eomes in NK Cell Development
A model of NK cell development is proposed based on the cell surface expression of indicated molecules. Gordon et al. (2012) showed that T-bet support the
NK cell lineage and is required to stabilize the immature TRAIL+ NK cell pool (stage 3a). T-bet and Eomes are later both required for the differentiation in
DX5+CD11b+ NK cells. The timeline of T-bet and Eomes actions on NK cell development is indicated by the dashed lines.
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Eomes, Eomes-deficient NK cells dis-
played an altered Ly49 receptor reper-
toire. Interestingly, the deletion of Eomes
in vitro did not alter the expression of the
Ly49molecules, suggesting an epigenetic
imprinting on the Ly49 locus.
In the absence of both Eomes and
T-bet, NK cells lose the expression of
the NK cell lineage markers NK1.1 and
NKp46. This striking observation is
consistent with the absence of linNK1.1+
NK cells in the BM, liver, or spleen of
Eomes T-bet double-deficient mice
although the number of stage 1 NKPs is
not affected. Thus, the absence of
NK1.1+NKp46+ NK cells in Eomes T-bet
double-deficient mice argue for a redun-
dant but critical role of Eomes and T-bet
in the acquisition of NK1.1 and NKp46
markers and further differentiation. Alto-
gether these results suggest that T-bet
is the transcription factor involved the
stabilization of the immature TRAIL+ NK
cells pool. T-bet and Eomes expressions
are later both required for the differentia-
tion in DX5+CD11b+ NK cells and pro-
gression toward KLRG1+CD43+ NK cells
(stage 6). The expression of Eomes
alone does not account for the terminal
differentiation of NK cells, which is consis-
tent with previous observations showing
that GATA-3-deficient NK cells do not
fully mature into KLRG1+CD43+ NK cells
(Samson et al., 2003). Based on these
results, it has been suggested that
GATA-3 could regulate T-bet expression
in NK cells. It would be thus interesting2 Immunity 36, January 27, 2012 ª2012 Elsevto determine whether it is also the case
for Eomes.
Gordon et al. (2012) also provide
insights in the regulation of NK cell
effector functions by T-box factors.
EomesTRAIL+DX5 WT NK cells are
good producers of TNF-a, whereas only
a few Eomes+DX5+ NK cells are able to
produce this cytokine. In addition,
Eomes-deficient and Eomes WT NK
cells express high amounts of granzyme
C and this expression is lost upon matu-
ration into Eomes+ NK cells. In contrast,
Eomes+ NK cells express higher amounts
of perforin, which is consistent with the
role of Eomes at controlling perforin
expression in CD8+ T cells (Pearce
et al., 2003). Upon phorbol myristate
acetate (PMA) + ionomycin or IL-12 + IL-
18 stimulation, there is an increased
proportion of cells able to produce
IFN-g in the Eomes+ as compared to
Eomes NK cell population. T-bet ex-
pression is not required for this response.
T-bet is, however, involved in the expres-
sion of granzyme B but not Eomes.
Eomes+T-bet+ NK cells are more potent
to degranulate as shown by the surface
exposition of the degranulation marker
CD107a as compared to Eomes WT or
Eomes+T-bet-deficient NK cells. Interest-
ingly, NK cells temporally deficient for
both Eomes and T-bet still express gran-
zyme B, IFN-g, and CD107a maybe
because of the previous imprinting of
the T-box transcription factors on these
effector genes or more probably because
NK cells acquire their effector activitiesier Inc.when acquiring the NK cell lineage
marker NKp46 (Narni-Mancinelli et al.,
2011).
Several transcription factors are in-
volved in NK cell development, including
Id2, PU.1, Ets-1, Ikaros, TOX, E4BP4,
MEF,GATA-3, andBlimp-1 (Martı´n-Fonte-
cha et al., 2011). The findings fromGordon
et al. (2012) reveal the role of T-bet
and Eomes as key checkpoints of NK cell
development, although more work is re-
quired to precisely determine the precise
choreography of all these transcription
factor in the shaping of NK cell lineage.ACKNOWLEDGMENTS
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A hallmark of the adaptive immune response is rapid and robust activation upon rechallenge. In the current
issue of Immunity, van der Windt et al., (2012) provide an important link between mitochondrial respiratory
capacity and the development of CD8+ T cell memory.At one time, a rite of passage for success-
fully mastering basic biochemistry was
memorizing (at least long enough to recite
on an exam) the tricarboxylic acid (TCA)
cycle and associated pathways leading
to the generation of cellular ATP. The
current work of the Pearce lab is forcing
us to dust off our old Stryer and/or
Lehninger tomes (or is there an App for
that?) in order to reexamine the role of
these pathways in the development of
T cell memory.
Perhaps only rivaled by cancer cells,
lymphocyte activation requires an extra-
ordinary amount of energy and biochem-
ical substrates to facilitate expansive
cellular division (Fox et al., 2005). Similar
to cancer cells, T cells employ aerobic
glycolysis as a means of not only gener-
ating ATP but also providing substrates
for the generation of nucleic acids, fats,
and proteins. Indeed, an integral aspect
of CD28-mediated costimulation is not
only the elaboration of cytokines but also
the upregulation of glucose transporters
and the activation of biochemical path-
ways necessary to support these meta-
bolic demands (Frauwirth and Thompson,
2004). Along these lines, more recently,
a critical role for myc in the upregulation
of metabolic machinery necessary for
T cell activation has been described
(Wang et al., 2011). It was shown thatmyc-mediated transcription plays a crit-
ical role in the upregulation of genes
responsible for driving glycolysis but is
not essential for fatty acid oxidation (FAO)
and increasing the oxygen consumption
rate (OCR). Likewise, mammalian target
of rapamycin (mTOR) activation, which
has been shown to play an important role
in regulating CD4+ T effector cell genera-
tion, also plays an important role in the
expression of proteins involved in glycol-
ysis and glucose uptake (Powell et al.,
2011). Thus, it is clear that increases in
the metabolic machinery are not simply
the consequences of T cell activation but
actually play an integral role in promoting
T cell activation (Fox et al., 2005). Along
these lines, it has been shown that in
addition to failing to produce cytokines
upon rechallenge, anergic T cells fail to
express the metabolic machinery neces-
sary for T cell activation (Zheng et al.,
2009). In other words, the upregulation of
metabolic programs promotes the activa-
tion of T cells, whereas the inhibition of
such programs inhibits T cell function.
The initial antigen encounter leads to
a massive increase in the frequency
of CD8+ effector cells (Araki et al.,
2010). Following this expansion there
is a contraction phase that ultimately
results in the emergence of long-living
CD8+ memory T cells with the capabilityto respond rapidly and robustly upon
secondary rechallenge. Thus, memory
cells have a unique set of metabolic
demands. On the one hand, they must
employ pathways that facilitate their
long-term survival. On the other hand,
they must respond upon rechallenge
even more vigorously than naive T cells.
Van der Windt et al., (2012) in this issue
of Immunity sought to determine the
role of metabolism in regulating the
generation and maintenance of memory
cells. Their studies reveal that memory
CD8+ T cells possessed a markedly in-
creased mitochondrial spare respiratory
capacity (SRC) when compared to
effector T cells. SRC refers to the extra
mitochondrial ability in a cell to generate
energy under conditions of great demand.
That is, SRC can be thought of as
measuring how close a cell is to its
‘‘bioenergetic limit’’ (Nicholls, 2009).
The increase in SRC is dependent upon
interleukin-15 (IL-15) signaling, which is
already known to play a critical role in
the generation of CD8+ T cell memory.
The generation of memory CD8+ T cells
by exposure to IL-15 concomitantly led
to an increase in mitochondrial biogen-
esis. When compared to CD8+ effector
cells, memory cells were shown to
have increased mitochondrial membrane
potential and less superoxide production,36, January 27, 2012 ª2012 Elsevier Inc. 3
